EUVIMEDEUVIMED entdecken
Crossref

Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells

Xiangkai Wei, Guoliang Zhang, Qian Liu, Zhiyuan Niu, Chunhong Chu, Chenxue Liu, Ke Wang, Lanxin Li, Rui Wang, Wenrui Cui, Huixia Xu, Chenyang Liu und 2 weitere

Clinical and Translational Oncology · 2024

DOI: 10.1007/s12094-024-03494-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Xiangkai Wei und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Affiliated Hospital of Henan University, Henan University, No. 357, Ximen Avenue, Kaifeng, 475000, Henan, Chi…. Hauptthemen laut MEDLINE: ErbB Receptors, Mutation, Protein Kinase Inhibitors, Apoptosis. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsMutationProtein Kinase InhibitorsApoptosisCell ProliferationHumansCell Line, TumorLung NeoplasmsCell SurvivalPyrazinesIndazolesCarcinoma, Non-Small-Cell LungAntineoplastic AgentsCell CycleMorpholines

Stichwörter der Autor:innen

AlflutinibAlmonertinibCytotoxicologyEGFRMutantTyrosine kinase inhibitor

Substanzen

ErbB ReceptorsEGFR protein, humanProtein Kinase Inhibitors6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-aminePyrazinesIndazolesAntineoplastic AgentsMorpholines

Autor:innen und Institutionen

  • Department of Anesthesiology, The First Affiliated Hospital of Henan University, Henan University, No. 357, Ximen Avenue, Kaifeng, 475000, Henan, China.
  • Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, No. 115, Ximen Avenue, Kaifeng, 475000, China.
  • Institutes of Traditional Chinese Medicine, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
  • Department of Anesthesiology, The First Affiliated Hospital of Henan University, Henan University, No. 357, Ximen Avenue, Kaifeng, 475000, Henan, China. Wangy1528@126.com.
  • Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, No. 115, Ximen Avenue, Kaifeng, 475000, China. anlei@henu.edu.cn.
  • Institutes of Traditional Chinese Medicine, School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China. anlei@henu.edu.cn.

Zitieren

APA

Wei, X., Zhang, G., Liu, Q., Niu, Z., Chu, C., Liu, C., Wang, K., Li, L., Wang, R., Cui, W., Xu, H., Liu, C., Wang, Y., & An, L. (2024). Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03494-5

Vancouver

Wei X, Zhang G, Liu Q, Niu Z, Chu C, Liu C, et al. Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03494-5

BibTeX
@article{Wei2024,
  author = {Wei, Xiangkai and Zhang, Guoliang and Liu, Qian and Niu, Zhiyuan and Chu, Chunhong and Liu, Chenxue and Wang, Ke and Li, Lanxin and Wang, Rui and Cui, Wenrui and Xu, Huixia and Liu, Chenyang and Wang, Ying and An, Lei},
  title = {Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells},
  journal = {Clinical and Translational Oncology},
  year = {2024},
  doi = {10.1007/s12094-024-03494-5}
}
Kostenlos starten →